|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 25/08 | |
| A61K 31/165 | |||
| A61P 9/06 |
| (11) | Patento numeris | 2345455 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11002768.7 |
| Europos patento paraiškos padavimo data | 2007-06-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-07-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-03-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 06013655 | 2006-06-30 | EP | |
| 06021469 | 2006-10-12 | EP | |
| 06021470 | 2006-10-12 | EP | |
| 06024241 | 2006-11-22 | EP |
| (72) |
Beyreuther, Bettina, DE
Heers, Cara, DE
Stöhr, Thomas, BE
|
| (73) |
UCB Pharma GmbH,
Alfred-Nobel-Strasse 10, 40789 Monheim,
DE
|
| (54) | Lacosamide for the treatment of hyperexcitability disorders associated with sodium channel dysfunction |
| Lacosamide for the treatment of hyperexcitability disorders associated with sodium channel dysfunction |